These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 15265661)

  • 21. In vivo administration of corticotropin-releasing hormone at remote intervals following ischemia enhances CA1 neuronal survival and recovery of spatial memory impairments: a role for opioid receptors.
    Charron C; Fréchette S; Proulx G; Plamondon H
    Behav Brain Res; 2008 Mar; 188(1):125-35. PubMed ID: 18055027
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential uses of corticotropin-releasing hormone antagonists.
    Zoumakis E; Rice KC; Gold PW; Chrousos GP
    Ann N Y Acad Sci; 2006 Nov; 1083():239-51. PubMed ID: 17148743
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rofecoxib, a selective cyclooxygenase-2 (COX-2) inhibitor increases pentylenetetrazol seizure threshold in mice: possible involvement of adenosinergic mechanism.
    Akula KK; Dhir A; Kulkarni SK
    Epilepsy Res; 2008 Jan; 78(1):60-70. PubMed ID: 18054463
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Corticotropin-releasing hormone receptor 1 antagonist blocks brain-gut activation induced by colonic distention in rats.
    Saito K; Kasai T; Nagura Y; Ito H; Kanazawa M; Fukudo S
    Gastroenterology; 2005 Nov; 129(5):1533-43. PubMed ID: 16285953
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beneficial effects of ceftriaxone against pentylenetetrazole-evoked convulsions.
    Jelenkovic AV; Jovanovic MD; Stanimirovic DD; Bokonjic DD; Ocic GG; Boskovic BS
    Exp Biol Med (Maywood); 2008 Nov; 233(11):1389-94. PubMed ID: 18703755
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of corticotropin-releasing hormone in blastocyst implantation and early fetal immunotolerance.
    Kalantaridou SN; Zoumakis E; Makrigiannakis A; Godoy H; Chrousos GP
    Horm Metab Res; 2007 Jun; 39(6):474-7. PubMed ID: 17578767
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of pentylenetetrazole-induced seizures and oxidative stress parameters by sodium valproate in the absence and presence of N-acetylcysteine.
    Uma Devi P; Pillai KK; Vohora D
    Fundam Clin Pharmacol; 2006 Jun; 20(3):247-53. PubMed ID: 16671959
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Corticotropin-releasing hormone (CRH) regulates macromolecular permeability via mast cells in normal human colonic biopsies in vitro.
    Wallon C; Yang PC; Keita AV; Ericson AC; McKay DM; Sherman PM; Perdue MH; Söderholm JD
    Gut; 2008 Jan; 57(1):50-8. PubMed ID: 17525093
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-epileptogenic effect of beta-carotene and vitamin A in pentylenetetrazole-kindling model of epilepsy in mice.
    Sayyah M; Yousefi-Pour M; Narenjkar J
    Epilepsy Res; 2005 Jan; 63(1):11-6. PubMed ID: 15716082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ang II and Ang III modulate PTZ seizure threshold in non-stressed and stressed mice: possible involvement of noradrenergic mechanism.
    Tchekalarova J; Georgiev V
    Neuropeptides; 2006 Oct; 40(5):339-48. PubMed ID: 17045647
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antisocial and seizure susceptibility phenotypes in an animal model of epilepsy are normalized by impairment of brain corticotropin-releasing factor.
    Turner LH; Lim CE; Heinrichs SC
    Epilepsy Behav; 2007 Feb; 10(1):8-15. PubMed ID: 17027340
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypersensitivity to pentylenetetrazol-induced convulsion in mice lacking the PLC-related inactive protein-1.
    Yamaguchi T; Kubota T; Kanematsu T; Nakayama K; Hirata M; Yamamoto T
    Brain Res; 2004 Oct; 1025(1-2):237-40. PubMed ID: 15464766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence that corticotropin-releasing hormone inhibits cell growth of human breast cancer cells via the activation of CRH-R1 receptor subtype.
    Graziani G; Tentori L; Muzi A; Vergati M; Tringali G; Pozzoli G; Navarra P
    Mol Cell Endocrinol; 2007 Jan; 264(1-2):44-9. PubMed ID: 17097220
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Seizure susceptibility alteration following reversible cholestasis in mice: Modulation by opioids and nitric oxide.
    Gholipour T; Riazi K; Noorian AR; Jannati A; Honar H; Doratotaj B; Nik HH; Shariftabrizi A; Dehpour AR
    Eur J Pharmacol; 2008 Feb; 580(3):322-8. PubMed ID: 18164287
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pentylenetetrazole-induced convulsions affect cellular and molecular parameters of the mechanism of action of triiodothyronine in adult rat brain.
    Bolaris S; Constantinou C; Valcana T; Margarity M
    Neuropharmacology; 2005 May; 48(6):894-902. PubMed ID: 15829259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A CRH1 antagonist into the amygdala of mice prevents defeat-induced defensive behavior.
    Robison CL; Meyerhoff JL; Saviolakis GA; Chen WK; Rice KC; Lumley LA
    Ann N Y Acad Sci; 2004 Dec; 1032():324-7. PubMed ID: 15677442
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overproduction of corticotropin-releasing hormone blocks germinal center formation: role of corticosterone and impaired follicular dendritic cell networks.
    Murray SE; Rosenzweig HL; Johnson M; Huising MO; Sawicki K; Stenzel-Poore MP
    J Neuroimmunol; 2004 Nov; 156(1-2):31-41. PubMed ID: 15465594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of beta-endorphin, corticotropin-releasing hormone, and autonomic nervous system in mediation of the effect of chronic ethanol on natural killer cell cytolytic activity.
    Boyadjieva N; Advis JP; Sarkar DK
    Alcohol Clin Exp Res; 2006 Oct; 30(10):1761-7. PubMed ID: 17010143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvement of CRH receptors in urocortin-induced hyperthermia.
    Telegdy G; Adamik A
    Peptides; 2008 Nov; 29(11):1937-42. PubMed ID: 18775757
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of corticotropin-releasing hormone (CRH) on the synthesis and secretion of proopiomelanocortin-related peptides in the anterior pituitary: a study using CRH-deficient mice.
    Fukuda Y; Kageyama K; Nigawara T; Kasagi Y; Suda T
    Neurosci Lett; 2004 Sep; 367(2):201-4. PubMed ID: 15331153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.